Osaka, Japan, January 13, 2015 --- Takeda Pharmaceutical Company Limited (Takeda) announced today that Christophe Weber, President and Chief Operating Officer will make a formal presentation on the company today U.S. time at the 33rd Annual J.P. Morgan Healthcare Conference held in San Francisco, Cal.
The details such as the timeline of the presentation and access to its live audio webcast and the archived presentation materials are as mentioned below.
|Date and time of the presentation||Tuesday January 13, at 9:30am – 9:55am PST
(Wednesday 14, at 2:30am – 2:55am, JST)
|Presenter||Christophe Weber, President and Chief Operating Officer|
|Agenda||・Strategic Roadmap Global Organization
・Sustaining Sales Growth
・Leadership in Oncology and Gastroenterology
Note: Including the sales update of Entyvio® during October - December 2014.
|Access to a live audio webcast and presentation materials||http://jpmorgan.metameetings.com/confbook/healthcare15/directlink.php?p=16861
Note: Registration through accessing this URL in advance is required.
Presentation materials will be available also at the company website at the same time of the presentation;
Note: Audio and materials are available only in English.
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.